Effectiveness and Safety of Tildrakizumab in the Treatment of Genital Psoriasis in Austria, Switzerland, and the Czech Republic
Latest Information Update: 03 Feb 2025
At a glance
- Drugs Tildrakizumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms CZATCH-Genital-PsO
- Sponsors Almirall S.A.
Most Recent Events
- 29 Jan 2025 Planned End Date changed from 1 Jul 2025 to 1 Mar 2026.
- 29 Jan 2025 Planned primary completion date changed from 1 Jul 2025 to 1 Mar 2026.
- 29 Jan 2024 Status changed from not yet recruiting to recruiting.